Eric Faulkner

Eric Faulkner

Company: Novartis Gene Therapies

Job title: VP, Global RWE


Generating Post-Approval Real World Evidence (RWE) to Support Overall Value Proposition 8:00 am

Comprehensive RWE data collection can support pricing decisions, particularly on outcome-based agreements More long-term data is needed to back up overall gene therapy safety and effectiveness Exploring the best tools and strategies to collect RWERead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.